Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov

摘要

BackgroundClinicalTrials.gov is valuable for aggregate-level analysis of trials. The recently published final rule aims to improve reporting of trial results. We aimed to assess variability in ClinicalTirals.gov records reporting participants’ baseline measures.